Phase 1 Clinical Trial of a Novel Proteasome Inhibitor (NPI-0052) in Patients with Lymphomas and Solid Tumors.
Autor: | Kurzrock, Razelle *, Hamlin, Paul *, Younes, Anas *, Hong, David *, Gordon, Michael *, Spear, Matthew A. *, Palladino, Michael A. *, Lloyd, G. Kenneth *, Longenecker, Angie M. *, Neuteboom, Saskia T.C. *, Cropp, Gillian F. *, Hannah, Alison *, Aghajanian, Carol * |
---|---|
Zdroj: | In Blood 16 November 2007 110(11):4504-4504 |
Databáze: | ScienceDirect |
Externí odkaz: |